How should we treat portopulmonary hypertension?

Krowka M. J., Swanson K. L.

Source: Eur Respir J 2006; 28: 466-467
Journal Issue: September

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Krowka M. J., Swanson K. L.. How should we treat portopulmonary hypertension?. Eur Respir J 2006; 28: 466-467

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview
Source: Eur Respir Rev 2012 21:223-233
Year: 2012



Portopulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary vascular diseases
Year: 2021


Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005

An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension
Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
Year: 2019



Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006

Iloprost treatment in portopulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Source: Eur Respir Monogr 2019; 86: 262-277
Year: 2019


Hepatopulmonary syndrome following portopulmonary hypertension
Source: Eur Respir J 2007; 29: 1277-1280
Year: 2007



Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension?
Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020
Year: 2020



Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: 563-567
Year: 2006



How to manage patients with arterial hypertension in the era of COVID-19
Source: COVID-19 Videos
Year: 2020

Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation
Source: Annual Congress 2003 - Pulmonary hypertension
Year: 2003


Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Source: Eur Respir J 2007; 30: 1096-1102
Year: 2007



Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension
Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension
Year: 2003